A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial

Autor: Sharma, Alok, Shah, Mili, Lakshmi, Satya, Sane, Hemangi, Captain, Jignasha, Gokulchandran, Nandini, Khubchandani, Pallavi, Pradeep, M.K., Gote, Prakash, Tuppekar, Balaji, Kulkarni, Pooja, Paranjape, Amruta, Pradhan, Radhika, Varghese, Ritu, Kasekar, Sushil, Nair, Vivek, Khanbande, Ummeammara

Publikováno v: In International Immunopharmacology July 2021 96

Corrigendum to "A pilot study for treatment of COVID-19 patients in moderate stage using intravenous administration of ozonized saline as an adjuvant treatment-registered clinical trial" [Int. Immunopharmacol. 96 (2021) 107743].

Autor: Sharma, Alok¹ (AUTHOR), Shah, Mili² (AUTHOR), Lakshmi, Satya³ (AUTHOR), Sane, Hemangi⁴ (AUTHOR), Captain, Jignasha⁵ (AUTHOR), Gokulchandran, Nandini¹ (AUTHOR), Khubchandani, Pallavi¹ (AUTHOR), Pradeep, M.K.⁵ (AUTHOR), Gote, Prakash¹ (AUTHOR), Tuppekar, Balaji¹ (AUTHOR), Kulkarni, Pooja^1,4 (AUTHOR) publications@neurogen.in, Paranjape, Amruta⁴ (AUTHOR), Pradhan, Radhika⁴ (AUTHOR), Varghese, Ritu⁴ (AUTHOR), Kasekar, Sushil¹ (AUTHOR), Nair, Vivek¹ (AUTHOR), Khanbande, Ummeammara¹ (AUTHOR)

Publikováno v: International Immunopharmacology. Jan2022, Vol. 102, pN.PAG-N.PAG. 1p.